Part of Kytogenics Pharmaceuticals Ltd., Chitogenics, Inc. is a company headquartered in the United States that provides medical equipment repairing services.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Researches and develops a small number of ethical pharmaceutical and medical products

Pharmasyntez JSC is a private company headquartered in Irkutsk, Russia, also operating in Russia, that develops and manufactures pharmaceutical products.

A leader in therapeutic antibodies, ImClone Systems (also called "the company") is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. Founded in 1984, ImClone has a rich culture of discovery and deep expertise in oncology. The company has utilized the many advances made in the fields of molecular biology, oncology, genomics, and antibody engineering to build a novel pipeline of product candidates designed to address specific genetic mechanisms involved in cancer growth and development. Beyond its blockbuster marketed product ERBITUX®, ImClone has several additional investigational monoclonal antibodies in various stages of clinical development. Following its acquisition by Eli Lilly and Company in 2008, ImClone Systems is accelerating its antibody pipeline development by leveraging Lilly's global capabilities. ImClone's pipeline has several molecules in mid- to late-stage clinical development targeting virtually all major solid tumor types. Additionally, ImClone plans to advance several additional targets from its research programs into clinical development over the coming years. ImClone's research and clinical development capabilities are augmented by its expertise in the scale-up and manufacturing of biologics. The company's state-of-the-art FDA-approved manufacturing facilities in Branchburg, New Jersey, provide it with one of the largest biologic manufacturing capacities in the world. ImClone's Branchburg campus also houses it clinical development and administration operations. The company's research headquarters are based in New York City and it has international operations in Europe.

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

Jiangsu Jetta Software Engineering Co., Ltd., established on 2003-09-30, Business scope includes sales of medical devices(Operate according to the scope listed in the license).Development of computer hardware, software and instruments,Sales,repair,Electronic computer network engineering design and construction,Cultural office machinery sales,Computer Technology Services,technical consulting,Self-operated and agent import and export of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ketu Medicine was established in August 2016 by Dr. Sun Zhijian, former senior researcher of BeiGene, Mr. Kang Ping, former co-founder of ACROBiosystems, and Professor Xie Dong, professor/chief scientist of the Institute of Nutrition, Chinese Academy of Sciences. founded. Ketu Medicine is the earliest domestic company focusing on the research and development and commercial transformation of organoid technology. The core team members have served in well-known pharmaceutical companies, hospitals, scientific research and CROs such as Novartis, BeiGene, GE Healthcare, Chinese Academy of Sciences, 301 Hospital, etc. service organization.